{
    "2020-10-27": [
        [
            {
                "time": "",
                "original_text": "康希诺新冠疫苗商品名确定：克威莎！年产能可达3亿剂",
                "features": {
                    "keywords": [
                        "康希诺",
                        "新冠疫苗",
                        "克威莎",
                        "年产能",
                        "3亿剂"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "前三季度研发费用同比增长86.82% 康希诺明星产品有望年内上市",
                "features": {
                    "keywords": [
                        "康希诺",
                        "研发费用",
                        "同比增长",
                        "明星产品",
                        "年内上市"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "思源股份、德源药业精选层申报材料获受理 累计受理企业达83家",
                "features": {
                    "keywords": [
                        "思源股份",
                        "德源药业",
                        "精选层",
                        "申报材料",
                        "受理企业",
                        "83家"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "其他行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "鑫开元：打造中国最专业的“一站式”CRO平台",
                "features": {
                    "keywords": [
                        "鑫开元",
                        "CRO平台",
                        "一站式",
                        "专业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国资委副主任翁杰明：纵深推进“双百企业”综合改革 率先完成重点任务",
                "features": {
                    "keywords": [
                        "国资委",
                        "翁杰明",
                        "双百企业",
                        "综合改革",
                        "重点任务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "超20家中国公司参与 涉及药物30多款 Q3授权交易特点有这些",
                "features": {
                    "keywords": [
                        "中国公司",
                        "药物",
                        "授权交易",
                        "Q3",
                        "特点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}